series-b
Stage
About
Sapience Therapeutics is a clinical-stage biotechnology company developing novel peptide therapeutics targeting oncogenic proteins for cancer treatment, including compounds in clinical trials for glioblastoma and colorectal cancer.
Explore Sapience Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.